Table 2 Summary of IC50s for pharmacological inhibitors of T-type VGCCs on lymphatic contraction amplitude and frequency.
Drug | Species | LV location | IC50 for amplitude | IC50 for frequency |
---|---|---|---|---|
Mibefradil | Rat | Mesenteric | 66 nM | 423 nM |
Ni2+ | Rat | Mesenteric | 248 µM | 279 µM |
Mouse | IAL | 66 µM | 1287 µM | |
Mouse | Popliteal | 110 µM | 452 µM | |
TTA-A2 | Mouse | Popliteal | 1.3 µM | nd |